DiaMedica Therapeutics (DMAC) Long-Term Investments (2023 - 2025)
DiaMedica Therapeutics (DMAC) reported Long-Term Investments of $1.0 million for Q1 2025, down 89.74% quarter-over-quarter from $9.7 million in Q3 2023.
DiaMedica Therapeutics (DMAC) Long-Term Investments (2023 - 2025) Analysis & Trends
DiaMedica Therapeutics has reported Long-Term Investments for 2 years, with the latest figure at $1.0 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 5.17 Mn |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 5.75 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.00 Mn |
| Sep 30, 2023 | 9.75 Mn |
| Jun 30, 2023 | 20.30 Mn |